BLOG

Combining Forces: NK Cell Therapy and Standard Cancer Treatments

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Standard cancer treatments like chemotherapy and radiation therapy are cornerstones of modern oncology, effectively targeting and destroying cancer cells. However, these powerful treatments can also impact healthy cells, including those of the immune system. Many individuals undergoing these therapies are concerned about a weakened immune state. This raises an important question: how can we support the body’s natural defenses during this critical time? One approach being explored is the use of adjunctive immunotherapies, such as NK cell therapy, alongside standard treatments.

This article provides an overview of how Natural Killer (NK) cell therapy may be combined with conventional cancer treatments like chemotherapy. The goal is to help your immune system remain robust, potentially complementing the effects of your primary cancer treatment. It is not a replacement for standard therapy but a supportive measure to be considered in consultation with a physician.

The Challenge: Immune Suppression During Standard Cancer Therapy

Chemotherapy and radiation are designed to eliminate rapidly dividing cells. While this is effective against cancer, it can also affect other fast-growing cells in the body, such as hair follicles, cells lining the digestive tract, and, importantly, immune cells produced in the bone marrow. This can lead to a state of immunosuppression, where the body’s ability to fight off infections and patrol for abnormal cells is temporarily reduced.

A key component of this defense system is the NK cell. As part of the innate immune system, NK cells are the body’s first line of defense, capable of identifying and attacking abnormal cells without prior sensitization. When the numbers or activity of these cells decline due to treatment, the body’s immune surveillance may be compromised. Supporting this system is a key area of interest in integrative oncology.

What is NK Cell Therapy? A Brief Overview

NK cell therapy is a type of adoptive cell transfer immunotherapy. The process begins with a simple blood draw from the patient. From this sample, the patient’s own (autologous) NK cells are isolated. These cells are then taken to a specialized cell processing facility where they are activated and expanded in number over several weeks. This process creates a large, highly active population of the patient’s own NK cells.

Once the cultivation is complete, these reinforced NK cells are returned to the patient’s body through an intravenous (IV) infusion. The fundamental aim is to replenish the body’s pool of these important immune cells, thereby supporting the immune system’s natural functions. Because the therapy uses the patient’s own cells, the risk of rejection-related side effects is considered low, though temporary fever or fatigue can occur.

How NK Cell Therapy May Complement Chemotherapy and Radiation

Combining immunotherapy and chemotherapy is an area of active research. The rationale for using NK cell therapy as an adjunctive treatment alongside standard therapies is based on several key ideas. It is important to understand that this is not intended to replace or interfere with standard treatments but to work in parallel.

  • Supporting Immune Surveillance: By reintroducing a large number of active NK cells, the therapy aims to help restore the immune surveillance mechanism that may be weakened by chemotherapy or radiation. This could help the body manage any remaining cancer cells that were not eliminated by the primary treatment.
  • Potential for Synergistic Effects: Some studies suggest that certain chemotherapy agents can make cancer cells more visible or vulnerable to immune cells like NK cells. While more research is needed, the combination aims to create a more challenging environment for cancer cells by attacking them from two different angles: the direct action of chemotherapy and the immune-mediated action of NK cells.
  • A Gentle Approach to Immune Support: Treatment involves only a blood draw and an IV infusion, which is generally well-tolerated and does not require hospitalization. This allows patients to maintain their daily routines while undergoing treatment.

Key Considerations for Adjunctive Immunotherapy in Japan

When considering NK cell therapy, especially in combination with other treatments, it’s crucial to have a clear understanding of what it entails. This therapy is a supportive measure, and its suitability depends entirely on an individual’s specific medical situation, as determined by a physician.

In Japan, advanced treatments like NK cell therapy are regulated under the Act on the Safety of Regenerative Medicine. This ensures that cell processing and treatment administration adhere to strict national standards for safety and quality control. It’s also important to note that this is a form of private medical care, meaning it is not covered by Japanese public health insurance (it is a non-insured, or ‘jiyu-shinryo,’ treatment). All costs associated with the therapy must be covered by the patient.

What to Discuss with Your Doctor Before Proceeding

A thorough consultation with a qualified physician is the most important step. Your doctor can help you understand if this therapy is an appropriate option for you. Here are some points to discuss:

  • Your current diagnosis, cancer stage, and overall health.
  • The proposed timing of NK cell therapy in relation to your chemotherapy or radiation schedule.
  • The potential benefits and risks as they apply to your specific case.
  • The full treatment plan, including the number of infusions, duration, and total cost.
  • Any potential side effects, such as temporary fever or fatigue, and how they are managed.

Conclusion: An Informed Approach to Immune Support

Navigating cancer treatment can be complex. While standard therapies remain the foundation of care, supporting the body’s own immune system is a logical and increasingly explored strategy. Adjunctive NK cell therapy represents one such approach, aiming to reinforce your natural defenses while you undergo treatments like chemotherapy and radiation. It is not a cure, but a complementary therapy focused on supporting your overall immune health.

Making an informed decision requires personalized medical advice. At Grand Green Osaka Umekita Clinic, located in Osaka, we provide consultations to help you understand if this approach is suitable for your circumstances. For more detailed information about the NK cell therapy process, potential risks, and fees, please visit our main NK Cell Therapy page. Our website offers information in multiple languages to assist international visitors considering treatment options in Japan.

Learn more about NK Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact